You have 9 free searches left this month | for more free features.

City

Condition

Sintilimab, Cetuximab, Regorafenib,Combine,mCRC (1)

Overall Status

Not yet recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Tianjin Medical University Cancer Institute and Hospital (1)

Collaborator

Intervention

sintilimab,regofinib,cetuximab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

sintilimab，regofinib，cetuximab

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Sintilimab, Cetuximab, Regorafenib,Combine,mCRC Trial (Sintilimab,regofinib,cetuximab)

Not yet recruiting

Sintilimab, Cetuximab, Regorafenib,Combine,mCRC

Sintilimab，regofinib，cetuximab

(no location specified)

Feb 8, 2021